Comparative effects of fish oil supplementation and a leukotriene receptor antagonist [montelukast] on EIB [exercise-induced bronchoconstriction] and airway inflammation in asthma
Phase of Trial: Phase I
Latest Information Update: 14 Oct 2009
At a glance
- Drugs Eicosapentaenoic acid/docosahexaenoic acid; Montelukast
- Indications Asthma
- Focus Therapeutic Use
- 14 Oct 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 14 Oct 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jun 2008 New trial record.